Insiders · Profile

Bozic Carmen

EVP and CMO at Vertex Pharmaceuticals. Filing since 5 Sep 2023. CIK 0001790029

Company
Date
Role
Action
Shares
Amount
Of holding
26 Jun 2026
EVP and CMO
Sold on a plan
596
$287.57K
3.7%
18 Jun 2026
EVP and CMO
Sold on a plan
1,020
$471.41K
6.0%
15 Jun 2026
EVP and CMO
Sold on a plan
4,062
$1.83M
19.3%
5 Jun 2026
EVP and CMO
Sold on a plan
1,745
$785.25K
7.7%
29 May 2026
EVP and CMO
Sold on a plan
1,974
$888.30K
8.0%
15 May 2026
EVP and CMO
Sold on a plan
1,354
$613.97K
5.2%
12 May 2026
EVP and CMO
Sold on a plan
6,988
$3.14M
21.1%
27 Mar 2026
EVP and CMO
Sold on a plan
2,329
$1.05M
6.6%
13 Mar 2026
EVP and CMO
Sold on a plan
2,329
$1.12M
6.2%
27 Feb 2026
EVP and CMO
Sold on a plan
2,329
$1.12M
5.8%
7 Aug 2024
EVP and CMO
Sold on a plan
2,280
$1.09M
8.9%
24 Jul 2024
EVP and CMO
Sold on a plan
2,280
$1.11M
8.2%
10 Jul 2024
EVP and CMO
Sold on a plan
2,280
$1.11M
7.6%
26 Jun 2024
EVP and CMO
Sold on a plan
2,280
$1.08M
7.0%
12 Jun 2024
EVP and CMO
Sold on a plan
2,280
$1.09M
6.6%
29 May 2024
EVP and CMO
Sold on a plan
2,280
$1.02M
6.2%
14 Nov 2023
EVP and CMO
Sold on a plan
5,650
$2.15M
16.2%
31 Oct 2023
EVP and CMO
Sold on a plan
5,651
$2.01M
13.9%
17 Oct 2023
EVP and CMO
Sold on a plan
5,651
$2.11M
12.2%
3 Oct 2023
EVP and CMO
Sold on a plan
5,651
$1.95M
10.9%
19 Sep 2023
EVP and CMO
Sold on a plan
5,651
$1.98M
9.8%
5 Sep 2023
EVP and CMO
Sold on a plan
5,651
$1.99M
8.9%
22 decisions on file.